Sales Effectiveness
June 27th, 2011
No comments
Timeline: Key dates for cancer drugs Avastin Roche WASHINGTON (Reuters) – Roche Genentech unit is appealing a U.S. proposal of removing breast cancer as an approved use of Avastin, the world's best-selling cancer drugs with $ 6 billion in annual sales. A hearing on the appeal takes place on Tuesday and Wednesday.
Sales effectiveness – Optimize your sales voice